STOLFI, CARMINE
 Distribuzione geografica
Continente #
NA - Nord America 21.522
AS - Asia 3.093
EU - Europa 2.528
Continente sconosciuto - Info sul continente non disponibili 443
SA - Sud America 422
AF - Africa 46
OC - Oceania 9
Totale 28.063
Nazione #
US - Stati Uniti d'America 21.373
SG - Singapore 1.493
CN - Cina 570
IT - Italia 563
RU - Federazione Russa 374
BR - Brasile 348
DE - Germania 309
HK - Hong Kong 276
VN - Vietnam 240
UA - Ucraina 232
IE - Irlanda 226
BD - Bangladesh 183
SE - Svezia 178
GB - Regno Unito 163
FR - Francia 146
FI - Finlandia 133
JP - Giappone 83
CA - Canada 68
KR - Corea 61
PL - Polonia 55
IN - India 47
MX - Messico 34
ID - Indonesia 27
NL - Olanda 27
AR - Argentina 25
AT - Austria 24
IQ - Iraq 21
ES - Italia 19
BE - Belgio 18
ZA - Sudafrica 18
TR - Turchia 16
CO - Colombia 13
EC - Ecuador 12
LT - Lituania 12
JM - Giamaica 11
CL - Cile 9
AU - Australia 8
PH - Filippine 8
RO - Romania 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
PY - Paraguay 7
TN - Tunisia 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
EG - Egitto 6
UZ - Uzbekistan 6
DO - Repubblica Dominicana 5
GR - Grecia 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
MY - Malesia 5
NP - Nepal 5
PK - Pakistan 5
AL - Albania 4
VE - Venezuela 4
BB - Barbados 3
DK - Danimarca 3
DM - Dominica 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
NO - Norvegia 3
PS - Palestinian Territory 3
RS - Serbia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BO - Bolivia 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GE - Georgia 2
LB - Libano 2
MT - Malta 2
NI - Nicaragua 2
PE - Perù 2
TW - Taiwan 2
BG - Bulgaria 1
BH - Bahrain 1
BT - Bhutan 1
GD - Grenada 1
GI - Gibilterra 1
GP - Guadalupe 1
HT - Haiti 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
Totale 27.615
Città #
Woodbridge 5.208
Wilmington 4.611
Houston 4.455
Singapore 916
Fairfield 808
Ashburn 627
San Jose 508
Ann Arbor 464
Chandler 431
Seattle 323
Cambridge 279
Council Bluffs 269
Hong Kong 266
Beijing 225
Jacksonville 210
Dublin 204
Rome 185
Santa Clara 173
Medford 164
New York 161
Dearborn 128
The Dalles 124
Los Angeles 113
Buffalo 74
Lawrence 73
Hanoi 70
Tokyo 69
Helsinki 68
Boardman 60
Ho Chi Minh City 58
Moscow 53
Lauterbourg 52
Chicago 45
Dallas 45
San Diego 45
Milan 40
Monte Vista 38
London 37
Kraków 34
Zhengzhou 32
São Paulo 31
Munich 30
Menlo Park 28
Mülheim 27
North Charleston 26
Orem 25
Redondo Beach 23
Atlanta 22
Indianapolis 21
North Bergen 20
Phoenix 20
Chennai 19
Boston 18
Brussels 18
Jakarta 18
Nuremberg 18
Toronto 18
Brooklyn 17
Warsaw 17
Montreal 16
Seoul 16
Lappeenranta 15
Salt Lake City 15
Denver 14
Johannesburg 14
Redwood City 14
Naples 13
Rio de Janeiro 13
Shanghai 13
Belo Horizonte 12
Miami 12
Mountain View 12
Norwalk 12
Manchester 11
Newark 11
Palo Alto 11
San Francisco 11
Vienna 11
Bologna 10
Colorado Springs 10
Da Nang 10
Charlotte 9
Draper 9
Frankfurt am Main 9
Haiphong 9
Nanjing 9
Verona 9
Chengdu 8
Curitiba 8
Kilburn 8
Las Vegas 8
Mexico City 8
San Mateo 8
Turin 8
Washington 8
Baghdad 7
Columbus 7
Dhaka 7
Guangzhou 7
Hangzhou 7
Totale 22.590
Nome #
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 595
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 575
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 549
Regulation of gut inflammation and Th17 cell response by interleukin-21 521
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 510
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 505
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 500
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 497
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 491
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 484
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 483
The dual role of Smad7 in the control of cancer growth and metastasis 482
Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery 480
Colorectal cancer chemoprevention by mesalazine and its derivatives 479
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 478
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 474
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 470
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 470
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 469
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 469
Collagen matrix injection combined with flap repair for complex anal fistula 466
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 465
Autocrine regulation of IL-21 production in human T lymphocytes 465
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 458
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 457
The dual role of inflammation in colon carcinogenesis 453
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 447
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 444
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 443
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 441
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 440
Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages 440
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 439
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 426
Role of TH17 cytokines in the control of colorectal cancer 425
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 423
Molecular basis of the potential of mesalazine to prevent colorectal cancer 412
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 412
Peritoneal expression of Matrilysin helps identify early post-operative recurrence of colorectal cancer 406
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 398
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 395
Smad7 positively regulates keratinocyte proliferation in psoriasis 390
Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease 384
IL-21 is highly produced in Helicobacter pylori-infected gastric mucosa and promotes gelatinases synthesis 383
Interleukin-34 sustains pro-tumorigenic signals in colon cancer tissue 382
Interleukin-21 in cancer immunotherapy: Friend or foe? 349
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 343
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 320
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 271
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 267
Progranulin sustains STAT3 hyper-activation and oncogenic function in colorectal cancer cells 235
Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide 229
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 226
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 217
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 202
Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells 191
{STAT}3 Interactors as Potential Therapeutic Targets for Cancer Treatment 187
Molecular targets of mesalazine in colorectal cancer 158
Association between celiac disease and cancer 158
Follistatin-like protein 1 sustains colon cancer cell growth and survival 158
Aptamer linked to DNA nanostructures diverts its traffic inside cancer cells and improves its therapeutic efficacy 158
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 152
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 150
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 143
Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system 137
RORγt-Expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 133
Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases 125
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 121
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 114
Smad7 Sustains Stat3 Expression and Signaling in Colon Cancer Cells 113
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis 108
Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures 108
Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis 107
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response 106
Role of interleukin-34 in cancer 105
Bromodomain-containing 4 is a positive regulator of the inflammatory cytokine response in the gut 87
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 86
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 86
A novel tumour enhancer function of Insulin-like growth factor II mRNA-binding protein 3 in colorectal cancer 78
Anthelmintic Drugs as Emerging Immune Modulators in Cancer 77
The AtMYB11 gene from Arabidopsis is expressed in meristematic cells and modulates growth in planta and organogenesis in vitro 76
Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders? 76
Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells 75
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 75
Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial–Mesenchymal Transition and Correlates with Progression of the Disease 73
TRAIL-Sensitizing Effects of Flavonoids in Cancer 72
Impact of food additives on gut homeostasis 67
Editorial for the Special Issue “Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0” 65
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 64
CDT1 drives replication overlicensing and enhances tumorigenesis in the gut† 64
Targeted Therapy of Interleukin-34 as a Promising Approach to Overcome Cancer Therapy Resistance 61
Impact of Western Diet and Ultra-Processed Food on the Intestinal Mucus Barrier 60
Bromodomain-Containing 4 Is a Positive Regulator of Interleukin-34 Production in the Gut 60
Smad7 Antisense Oligonucleotide in Crohn’s Disease: A Re-Evaluation and Explanation for the Discordant Results of Clinical Trials 59
Rafoxanide sensitizes colorectal cancer cells to TRAIL-mediated apoptosis 58
Targeting Cancer Cell Energy Metabolism in Colorectal Cancer: Opportunities and Challenges from Drug Repositioning 56
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 54
High Smad7 marks inflammation in patients with chronic pouchitis 49
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue “State-of-the-Art Molecular Oncology in Italy” 46
Special Issue “Drug Treatments for Inflammatory Bowel Diseases” 41
Totale 27.731
Categoria #
all - tutte 76.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022706 0 0 55 19 28 58 57 28 90 73 68 230
2022/20231.077 97 101 26 133 113 211 91 83 106 28 63 25
2023/2024423 50 17 24 13 42 109 21 80 4 4 2 57
2024/20252.343 71 538 305 179 50 204 137 88 250 257 169 95
2025/20264.527 297 161 412 355 409 165 492 539 538 456 441 262
2026/2027828 346 256 226 0 0 0 0 0 0 0 0 0
Totale 28.063